Global Immunochemicals Market to Reach $6.4 Billion by 2030
The global market for Immunochemicals estimated at US$4.2 Billion in the year 2022, is projected to reach a revised size of US$6.4 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2022-2030. Catalog Antibodies, one of the segments analyzed in the report, is projected to record 4.6% CAGR and reach US$4.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Custom Antibodies segment is readjusted to a revised 6.9% CAGR for the next 8-year period.The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 5.1% CAGR
The Immunochemicals market in the U.S. is estimated at US$1.2 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 5.1% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.7% and 4.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.Select Competitors (Total 116 Featured) -
- Abcam Plc.
- Agilent Research Laboratories
- Beckman Coulter GmbH
- Biolegend Inc.
- Bio-Rad Laboratories Inc.
- Cell Signaling Technology Inc.
- GenScript Biotech Corporation
- PerkinElmer Inc.
- Rockland Immunochemicals Inc.
- Santa Cruz Biotechnology Inc.
- Sigma-Aldrich Corporation
- Thermo Fischer Scientific Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abcam Plc.
- Agilent Research Laboratories
- Beckman Coulter GmbH
- Biolegend Inc.
- Bio-Rad Laboratories Inc.
- Cell Signaling Technology Inc.
- GenScript Biotech Corporation
- PerkinElmer Inc.
- Rockland Immunochemicals Inc.
- Santa Cruz Biotechnology Inc.
- Sigma-Aldrich Corporation
- Thermo Fischer Scientific Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 312 |
Published | May 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 4.2 Billion |
Forecasted Market Value ( USD | $ 6.4 Billion |
Compound Annual Growth Rate | 5.4% |
Regions Covered | Global |